RNA polymerase II CTD is dispensable for transcription and required for termination in human cells

EMBO Rep. 2023 Sep 6;24(9):e56150. doi: 10.15252/embr.202256150. Epub 2023 Jul 10.

Abstract

The largest subunit of RNA polymerase (Pol) II harbors an evolutionarily conserved C-terminal domain (CTD), composed of heptapeptide repeats, central to the transcriptional process. Here, we analyze the transcriptional phenotypes of a CTD-Δ5 mutant that carries a large CTD truncation in human cells. Our data show that this mutant can transcribe genes in living cells but displays a pervasive phenotype with impaired termination, similar to but more severe than previously characterized mutations of CTD tyrosine residues. The CTD-Δ5 mutant does not interact with the Mediator and Integrator complexes involved in the activation of transcription and processing of RNAs. Examination of long-distance interactions and CTCF-binding patterns in CTD-Δ5 mutant cells reveals no changes in TAD domains or borders. Our data demonstrate that the CTD is largely dispensable for the act of transcription in living cells. We propose a model in which CTD-depleted Pol II has a lower entry rate onto DNA but becomes pervasive once engaged in transcription, resulting in a defect in termination.

Keywords: Pol II interactome; RNA polymerase II (Pol II); carboxy-terminal domain (CTD); mammalian transcription; termination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Nucleus / metabolism
  • Humans
  • Mutation
  • Phosphorylation
  • RNA Polymerase II* / metabolism
  • Transcription, Genetic*

Substances

  • RNA Polymerase II

Associated data

  • GEO/GSE210601